Tests whether sugar in the diet affects blood sugar problems in cystic fibrosis
Compares a low-sugar, high-fat diet with a standard cystic fibrosis diet in adults.
Key facts
- Who runs it
- Emory University
- Where
- Atlanta, United StatesSee the site
- Trial code
- Registry title
- FEED-Cystic Fibrosis (FEED-CF)
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 28 Jun 2023
- Expected to end
- 30 Jun 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Low-added sugar, high-fat diet
- High-added sugar, high-fat CF diet
- Record updated
- 3 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with cystic fibrosis who eat a lot of added sugar. They will get all their food for 8 weeks, either a low-added sugar diet or a standard CF diet.
- Age
- 18 years and older
- Sex
- All sexes can join.
- Disease stage
- Confirmed cystic fibrosis. People with a diagnosis of cystic fibrosis-related diabetes (CFRD) cannot join.
- Earlier treatment
- No change in medical regimen (including medicines and lung flare-ups) in the 21 days before the study visit. No start of a CFTR modulator in the previous 8 weeks.
- Biomarker or test result
- Estimated daily added sugar intake of more than 16 tsp on the Dietary Screener Questionnaire (DSQ). Fasting blood sugar below 126 mg/dL (7 mmol/L) on the screening glucose test.
Main reasons for not taking part
- Confirmed cystic fibrosis-related diabetes (CFRD)
- Night-time tube feeds
- BMI below 18.5 kg/m2
- Long-term steroid use
- Current pregnancy or breastfeeding
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Confirmed CF diagnosis
- Ages 18 years and older
- Baseline estimated daily total added sugar intake >16 tsp, as estimated from the Dietary Screener Questionnaire (DSQ)
Who cannot take part
- Chronic steroid use
- Clinically instability, defined as no changes in medical regimen (including medications and pulmonary exacerbations) for at least 21 days prior to study visit
- Initiation of CFTR modulator within previous 8 weeks OR unstable changes in weight and lung function due to CFTR modulator use
- Uncontrolled exocrine pancreatic insufficiency/malabsorption
- Any food allergies or intolerances that cannot be accommodated
- Any medical condition deemed by the a study physician or PI that may preclude completion of the study or interfere with primary end points
- Screening OGTT showing fasting hyperglycemia (≥126 mg/dL)
- Nocturnal tube feeds
- BMI <18.5 kg/m2
- Life expectancy < 12 months
- Confirmed diagnosis of CFRD
- Current pregnancy or lactation
- Inability/unwillingness to consume the majority of foods on the menu during the study period
- MRI-incompatible metal that cannot be removed for testing
- Actively trying to gain or lose weight
Where in United States
- Emory University HospitalAtlanta, United StatesContact: Swati Zaveri, PhDTaking people
About the trial
What the trial wants to find out
The goal of this study is to determine the extent to which excess dietary sugars serve as a precipitating factor in glucose intolerance in adults with cystic fibrosis (CF), a population at especially high risk for a unique form of diabetes (CF-related diabetes, CFRD) and with standard-of-care dietary recommendations (high-calorie, high-fat) that conflict with recommendations for other forms of diabetes.
Read full original descriptionShow less
This trial will investigate if the typical high-sugar, high-fat CF diet plays a role in diabetes risk and visceral fat accumulation in people with CF. A total of 30 participants will get a low-added sugar, high-fat diet and the other 30 will get a standard CF diet with no sugar restrictions. Participants will be randomized to the diet group they are assigned. All foods will be provided for 8 weeks.
The 2 groups in the trial
- Low-added sugar, high-fat diet ArmTreatment being tested
Patients will receive a low-added sugar, high-fat diet for 8 weeks. Study menus will be designed by registered dietitians using the Nutrient Database System for Research (NDSR) software program with a 2-wk rotation.Total kcal provided will be individually tailored to maintain body weight and adjusted throughout as needed. All foods (including snacks and drinks) for 8 wks will be delivered to participants' homes. Menus will be designed so that food will be delivered to subjects' homes every 3-4 days. It will be expected that participants consume only the foods provided by the study.
Treatment: Low-added sugar, high-fat diet
- Typical CF diet ArmExisting treatment, for comparison
Patients will receive a high-added sugar, high-fat CF diet for 8 weeks. Study menus will be designed by registered dietitians using the Nutrient Database System for Research (NDSR) software program with a 2-wk rotation. Total kcal provided will be individually tailored to maintain body weight and adjusted throughout as needed. All foods (including snacks and drinks) for 8 wks will be delivered to participants' homes. Menus will be designed so that food will be delivered to subjects' homes every 3-4 days. It will be expected that participants consume only the foods provided by the study.
Treatment: High-added sugar, high-fat CF diet
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Feeding Study to Optimize Endocrine Dysfunction in Cystic Fibrosis
- Plain-language title
- Tests whether sugar in the diet affects blood sugar problems in cystic fibrosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- Record updated
- 3 June 2026